These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

278 related articles for article (PubMed ID: 22566174)

  • 21. A simple method for the detection of insoluble aggregates in protein formulations.
    Li B; Flores J; Corvari V
    J Pharm Sci; 2007 Jul; 96(7):1840-3. PubMed ID: 17299781
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Variability in Flow-Imaging Microscopy Measurements and Considerations for Biopharmaceutical Development.
    Rauk AP; Griffiths KL; Gossage MD; Weiss WF
    J Pharm Sci; 2016 Nov; 105(11):3296-3303. PubMed ID: 27663382
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Biopharmaceutical formulations for pre-filled delivery devices.
    Jezek J; Darton NJ; Derham BK; Royle N; Simpson I
    Expert Opin Drug Deliv; 2013 Jun; 10(6):811-28. PubMed ID: 23506207
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Application of high hydrostatic pressure to dissociate aggregates and refold proteins.
    Seefeldt MB; Rosendahl MS; Cleland JL; Hesterberg LK
    Curr Pharm Biotechnol; 2009 Jun; 10(4):447-55. PubMed ID: 19519422
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Application of ultraviolet, visible, and infrared light imaging in protein-based biopharmaceutical formulation characterization and development studies.
    Klijn ME; Hubbuch J
    Eur J Pharm Biopharm; 2021 Aug; 165():319-336. PubMed ID: 34052429
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Monitoring of subvisible particles in therapeutic proteins.
    Singh SK; Toler MR
    Methods Mol Biol; 2012; 899():379-401. PubMed ID: 22735966
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Ion exchange chromatography of proteins and clearance of aggregates.
    Yigzaw Y; Hinckley P; Hewig A; Vedantham G
    Curr Pharm Biotechnol; 2009 Jun; 10(4):421-6. PubMed ID: 19519418
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Semi-Quantitative Analysis of Inherent Visible Particles for Biopharmaceutical Products.
    Cash PW; Narwal R; Levitskaya SV; Krause S; Murphy D; Mazaheri M
    PDA J Pharm Sci Technol; 2016; 70(2):134-42. PubMed ID: 26797974
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cubosomes as targeted drug delivery systems - a biopharmaceutical approach.
    Lakshmi NM; Yalavarthi PR; Vadlamudi HC; Thanniru J; Yaga G; K H
    Curr Drug Discov Technol; 2014; 11(3):181-8. PubMed ID: 24836404
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Characterization of subvisible particle formation during the filling pump operation of a monoclonal antibody solution.
    Nayak A; Colandene J; Bradford V; Perkins M
    J Pharm Sci; 2011 Oct; 100(10):4198-204. PubMed ID: 21698601
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Supercritical fluid (SCF)-assisted fabrication of carrier-free drugs: An eco-friendly welcome to active pharmaceutical ingredients (APIs).
    Kankala RK; Xu PY; Chen BQ; Wang SB; Chen AZ
    Adv Drug Deliv Rev; 2021 Sep; 176():113846. PubMed ID: 34197896
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Flow cytometry: a promising technique for the study of silicone oil-induced particulate formation in protein formulations.
    Ludwig DB; Trotter JT; Gabrielson JP; Carpenter JF; Randolph TW
    Anal Biochem; 2011 Mar; 410(2):191-9. PubMed ID: 21146492
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cross-linked silicone coating: a novel prefilled syringe technology that reduces subvisible particles and maintains compatibility with biologics.
    Depaz RA; Chevolleau T; Jouffray S; Narwal R; Dimitrova MN
    J Pharm Sci; 2014 May; 103(5):1384-93. PubMed ID: 24643773
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Differential scanning fluorimetry: rapid screening of formulations that promote the stability of reference preparations.
    Malik K; Matejtschuk P; Thelwell C; Burns CJ
    J Pharm Biomed Anal; 2013 Apr; 77():163-6. PubMed ID: 23416371
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Compatibility, physical stability, and characterization of an IgG4 monoclonal antibody after dilution into different intravenous administration bags.
    Kumru OS; Liu J; Ji JA; Cheng W; Wang YJ; Wang T; Joshi SB; Middaugh CR; Volkin DB
    J Pharm Sci; 2012 Oct; 101(10):3636-50. PubMed ID: 22733600
    [TBL] [Abstract][Full Text] [Related]  

  • 36. An industry perspective on the monitoring of subvisible particles as a quality attribute for protein therapeutics.
    Singh SK; Afonina N; Awwad M; Bechtold-Peters K; Blue JT; Chou D; Cromwell M; Krause HJ; Mahler HC; Meyer BK; Narhi L; Nesta DP; Spitznagel T
    J Pharm Sci; 2010 Aug; 99(8):3302-21. PubMed ID: 20310025
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Thermo-Optical Protein Characterization for Straightforward Preformulation Development.
    Wanner R; Breitsprecher D; Duhr S; Baaske P; Winter G
    J Pharm Sci; 2017 Oct; 106(10):2955-2958. PubMed ID: 28624419
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Early pharmaceutical profiling to predict oral drug absorption: current status and unmet needs.
    Bergström CA; Holm R; Jørgensen SA; Andersson SB; Artursson P; Beato S; Borde A; Box K; Brewster M; Dressman J; Feng KI; Halbert G; Kostewicz E; McAllister M; Muenster U; Thinnes J; Taylor R; Mullertz A
    Eur J Pharm Sci; 2014 Jun; 57():173-99. PubMed ID: 24215735
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Characterization of Protein-Excipient Microheterogeneity in Biopharmaceutical Solid-State Formulations by Confocal Fluorescence Microscopy.
    Koshari SH; Ross JL; Nayak PK; Zarraga IE; Rajagopal K; Wagner NJ; Lenhoff AM
    Mol Pharm; 2017 Feb; 14(2):546-553. PubMed ID: 28094996
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Immunogenicity assessment of therapeutic proteins and peptides.
    Kaliyaperumal A; Jing S
    Curr Pharm Biotechnol; 2009 Jun; 10(4):352-8. PubMed ID: 19519410
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.